I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
FIRBAS, C.
49
results:
Search for persons
X
Format
Online (48)
Print (1)
Mediatypes
Books (1)
Articles (Online) (35)
Bookchapter (Online) (1)
OpenAccess-fulltext (12)
Languages
german (7)
english (35)
Sorted by: Relevance
Sorted by: Year
?
1
Phase 2 clinical results: Chikungunya vaccine based on meas..:
Ramsauer, K.
;
Reisinger, E.
;
Firbas, C.
...
International Journal of Infectious Diseases. 79 (2019) - p. 118 , 2019
Link:
https://doi.org/10.1016/..
?
2
Anti-C1s monoclonal antibody BIVV009 in late antibody-media..:
Eskandary, F.
;
Jilma, B.
;
Mühlbacher, J.
...
American Journal of Transplantation. 18 (2018) 4 - p. 916-926 , 2018
Link:
https://doi.org/10.1111/..
?
3
The Pharmacodynamic Effects of Rituximab at Very Low Doses:
Schoergenhofer, C.
;
Firbas, C.
;
Derhaschnig, U.
...
Clinical Therapeutics. 39 (2017) 8 - p. e4 , 2017
Link:
https://doi.org/10.1016/..
?
4
Oc025—Reversal Strategy In Antagonizing The P2y12-Inhibitor..:
Hobl, E.-L.
;
Derhaschnig, U.
;
Firbas, C.
...
Clinical Therapeutics. 35 (2013) 8 - p. e10-e11 , 2013
Link:
https://doi.org/10.1016/..
?
5
Racial differences in endotoxin-induced tissue factor-trigg..:
MAYR, F. B.
;
SPIEL, A. O.
;
LEITNER, J. M.
...
Journal of Thrombosis and Haemostasis. 7 (2009) 4 - p. 634-640 , 2009
Link:
https://doi.org/10.1111/..
?
6
Influence of the Duffy Antigen on Pharmacokinetics and Phar..:
Mayr, F.B.
;
Spiel, A.O.
;
Leitner, J.M.
...
International Journal of Immunopathology and Pharmacology. 22 (2009) 3 - p. 615-625 , 2009
Link:
https://doi.org/10.1177/..
?
7
Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Trial ..:
Tauber, E.
;
Kollaritsch, H.
;
von Sonnenburg, F.
...
The Journal of Infectious Diseases. 198 (2008) 4 - p. 493-499 , 2008
Link:
https://doi.org/10.1086/..
?
8
Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial ..:
Tauber, E.
;
Kollaritsch, H.
;
Von Sonnenburg, F.
...
The Journal of Infectious Diseases. 198 (2008) 4 - p. 493-499 , 2008
Link:
https://www.jstor.org/st..
?
9
Effects of low dose endotoxemia on endothelial progenitor c..:
Mayr, F.B.
;
Spiel, A.O.
;
Leitner, J.M.
...
Atherosclerosis. 195 (2007) 1 - p. e202-e206 , 2007
Link:
https://doi.org/10.1016/..
?
10
Reparixin, a Specific Interleukin-8 Inhibitor, Has No Effec..:
Leitner, J.M.
;
Mayr, F.B.
;
Firbas, C.
...
International Journal of Immunopathology and Pharmacology. 20 (2007) 1 - p. 25-36 , 2007
Link:
https://doi.org/10.1177/..
?
11
Pharmacokinetics and Pharmacodynamics of the Dual FII/FX In..:
Leitner, J M
;
Jilma, B
;
Mayr, F B
...
Clinical Pharmacology & Therapeutics. 81 (2007) 6 - p. 858-866 , 2007
Link:
https://doi.org/10.1038/..
?
12
[605] THERAPEUTIC PEPTIDE VACCINATION AGAINST CHRONIC HEPAT..:
Klade, C.S.
;
Wedemeyer, H.
;
Sarrazin, C.
...
Journal of Hepatology. 46 (2007) - p. S229 , 2007
Link:
https://doi.org/10.1016/..
?
13
EFFECTS OF SHORT TERM STATIN PRE-TREATMENT AND SUBSEQUENT L..:
Spiel, A.O.
;
Mayr, F.B.
;
Leitner, J.M.
...
Journal of Thrombosis and Haemostasis. 5 (2007) - p. P-M-365-P-M-365 , 2007
Link:
https://doi.org/10.1111/..
?
14
588 Optimization of schedule, route and adjuvant of therape..:
Klade, C.S.
;
Firbas, C.
;
Bürger, V.
...
Journal of Hepatology. 44 (2006) - p. S218 , 2006
Link:
https://doi.org/10.1016/..
?
15
Recombinant human antithrombin inhibits thrombin formation ..:
LEITNER, J
;
FIRBAS, C
;
MAYR, F
...
Clinical Pharmacology & Therapeutics. 79 (2006) 1 - p. 23-34 , 2006
Link:
https://doi.org/10.1016/..
1-15